Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/i-mab-reports-full-year-2023-financial-results-and-business-update-302089532.html
https://www.biospectrumasia.com/news/26/23713/i-mab-divests-china-business-to-become-us-based-biotech-firm.html
https://www.fiercebiotech.com/biotech/i-mab-sheds-china-footprint-complete-transformation-us-based-biotech
https://www.prnewswire.com/news-releases/i-mab-announces-participation-at-jefferies-and-piper-conferences-in-november-301978319.html
https://www.prnewswire.com/news-releases/felzartamab-granted-breakthrough-therapy-designation-by-us-food-and-drug-administration-fda-for-primary-membranous-nephropathy-pmn-301975493.html
https://www.prnewswire.com/news-releases/i-mab-announces-poster-presentations-of-4-1bb-bispecific-antibody-portfolio-at-sitc-2023-301973914.html
https://www.prnewswire.com/news-releases/i-mab-announces-phase-1-data-of-givastomig-at-esmo-2023-301957219.html
https://www.prnewswire.com/news-releases/i-mab-and-abl-bio-announce-latest-updates-of-pd-l1-and-4-1bb-bispecific-antibody-tj-l14babl503-301951981.html
https://www.reuters.com/markets/deals/abbvie-terminates-deal-with-i-mab-develop-cancer-drug-2023-09-22/
https://www.prnewswire.com/news-releases/i-mab-announces-upcoming-participation-at-september-conferences-301917513.html